TY - JOUR
T1 - Risk of melanoma following adulthood cancer
T2 - A case-control study
AU - Dupuy, A.
AU - Shamsaldin, A.
AU - Quiniou, E.
AU - Paoletti, C.
AU - Labbé, M.
AU - Avril, M. F.
AU - Lefkopoulos, D.
AU - De Vathaire, F.
PY - 2005/12/1
Y1 - 2005/12/1
N2 - Melanoma is a severe skin cancer related to sun exposure. Whether this malignancy is linked to exposure to ionising radiation during adulthood is still controversial. This case-control study examined the risk of melanoma following treatment for an adulthood first malignant neoplasm (FMN). Cases were patients who presented with cutaneous melanoma after a first cancer in adulthood. Controls (3 per case) were patients free of melanoma, matched for age, duration of follow-up since the FMN, type of FMN, and followed in the same institution. A total of 57 cases and 171 controls were included. In the final multivariate analysis, no risk of melanoma was associated with radiotherapy (odds ratio (OR) for 1 Gy = 1.01, 95% confidence interval (95%CI) 0.96-1.07) nor hormonotherapy, whereas chemotherapy use (OR = 2.3, 95%CI 0.93-5.6) and having a history of familial cancer (OR = 2.8, 95%CI 1.3-5.9) exhibited a nearly significant risk. In conclusion, unlike the evidence for risk of exposure to ionising radiation during childhood, we did not substantiate a risk for association of melanoma with exposure to ionising radiation during adulthood. The risk associated with chemotherapy should justify the implementation of skin surveillance for early detection of melanoma in these patients.
AB - Melanoma is a severe skin cancer related to sun exposure. Whether this malignancy is linked to exposure to ionising radiation during adulthood is still controversial. This case-control study examined the risk of melanoma following treatment for an adulthood first malignant neoplasm (FMN). Cases were patients who presented with cutaneous melanoma after a first cancer in adulthood. Controls (3 per case) were patients free of melanoma, matched for age, duration of follow-up since the FMN, type of FMN, and followed in the same institution. A total of 57 cases and 171 controls were included. In the final multivariate analysis, no risk of melanoma was associated with radiotherapy (odds ratio (OR) for 1 Gy = 1.01, 95% confidence interval (95%CI) 0.96-1.07) nor hormonotherapy, whereas chemotherapy use (OR = 2.3, 95%CI 0.93-5.6) and having a history of familial cancer (OR = 2.8, 95%CI 1.3-5.9) exhibited a nearly significant risk. In conclusion, unlike the evidence for risk of exposure to ionising radiation during childhood, we did not substantiate a risk for association of melanoma with exposure to ionising radiation during adulthood. The risk associated with chemotherapy should justify the implementation of skin surveillance for early detection of melanoma in these patients.
KW - Anti-neoplastic combined chemotherapy protocols
KW - Melanoma
KW - Neoplasms, radiation-induced
KW - Neoplasms, second primary
UR - http://www.scopus.com/inward/record.url?scp=28244439365&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2005.07.020
DO - 10.1016/j.ejca.2005.07.020
M3 - Article
C2 - 16243516
AN - SCOPUS:28244439365
SN - 0959-8049
VL - 41
SP - 2904
EP - 2910
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 18
ER -